Summary
This epigenome-wide association study (EWAS) leveraged multiple large cohorts to identify DNA methylation sites associated with body mass index and investigate their relationship to obesity-related disease outcomes. As suggested by the title and journal scope, the research examined whether methylation markers could illuminate molecular pathways linking adiposity to adverse metabolic and cardiovascular sequelae. The findings contribute to understanding the epigenetic architecture of obesity and may inform future biomarker development and mechanistic research.
UK applicability
The study's multi-national cohort design (including UK-based samples such as TwinsUK) provides direct applicability to understanding obesity genetics and epigenetics in UK populations. Findings may support development of UK public health tools for identifying individuals at higher epigenetic risk of obesity-related disease, though translation to clinical practice or policy requires further validation.
Key measures
DNA methylation sites (CpG positions); body mass index; adiposity-related phenotypes and disease outcomes
Outcomes reported
The study identified DNA methylation sites associated with body mass index and investigated their relationship to adiposity-related adverse health outcomes. The research examined epigenome-wide associations across multiple cohorts to understand molecular mechanisms linking obesity to metabolic disease.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.